Optum Rx GLP-1 Coverage for Weight Loss (2026)

If your prescription card says Optum Rx, you have probably tried to figure out whether a GLP-1 medication for weight loss would be covered, and found the answer strangely hard to pin down. That is not you missing something. Optum Rx is not the one making the decision that matters most for your coverage.

Here is what Optum Rx’s own published documents say as of 2026-10-16, what your employer or health plan controls, and how to find out where your own plan stands.

Transformation Health is an independent guide, not a provider, and is not affiliated with Optum Rx, Optum, or UnitedHealth Group: we do not prescribe, sell medication, or work with insurance. This content is for general education and is not medical advice. Talk with a licensed provider about your situation.

First, what Optum Rx actually is

Optum Rx is a pharmacy benefit manager, or PBM. UnitedHealth Group lists it among its Optum businesses.^[1] A PBM does not insure you. It manages the prescription drug side of a health plan for whoever sponsors that plan, usually an employer or a health insurer. The PBM maintains the formulary, the list of covered medications and their cost tiers, and runs the prior authorization process when you fill a prescription.

Optum Rx runs the pharmacy benefit for UnitedHealthcare plans, along with employers and health plans that hire it directly. So your medical card might say UnitedHealthcare, or another company entirely, while your pharmacy card says Optum Rx. If you have a UnitedHealthcare plan, our guide to UnitedHealthcare GLP-1 coverage covers UnitedHealthcare’s own rules and criteria.

This structure matters because a PBM can list a medication on its formulary while your plan still excludes it. That is what happens with weight loss GLP-1s.

The short answer

Coverage depends on your plan, not on Optum Rx alone. As of 2026-10-16, Optum Rx’s 2026 Premium Standard Formulary lists Wegovy, Saxenda, and the Zepbound auto-injector pen with prior authorization and quantity limits.^[2][3] In several versions of the formulary, these drugs carry a “++” note, which the formulary defines as “Benefit design options - Coverage is determined by your prescription medication benefit plan."^[2][4]

In other words, the weight loss drugs are on the list, and your employer or health plan decides whether the list applies to you for weight loss. A version of the same formulary prepared for one plan sponsor lists Wegovy, Zepbound, and Saxenda as excluded (tier E).^[5] Both outcomes are possible under the Optum Rx name.

So the real question is not “does Optum Rx cover GLP-1s,” it is “does my plan include weight loss medications.” Each formulary also states that where it differs from your benefit plan, the benefit plan documents rule.^[2]

GLP-1 medications prescribed for type 2 diabetes are a separate coverage category, with their own criteria. This page is about coverage for weight management.

What Optum Rx’s 2026 formulary lists

These rows come from versions of the Optum Rx 2026 Premium Standard Formulary effective January 1, 2026 and July 1, 2026. Your plan may use a different Optum Rx formulary or a customized version, so treat this as a starting point.

The tier sets your share of the cost, and your employer or plan sponsor sets the cost for each tier.^[2] We did not find Foundayo (orforglipron), the oral GLP-1, listed at a covered tier in the versions we reviewed, so ask about it directly if it matters to you.

Prior authorization criteria. Optum Rx’s materials for employers say plans can limit anti-obesity medication coverage to the members who meet “the criteria defined by the plan,” and can choose to cover only the most at-risk groups.^[6] That means there is no single Optum Rx rule to quote here. Ask member services which criteria document applies to your plan. For reference, both Wegovy and Zepbound are FDA-approved, with a reduced-calorie diet and more physical activity, for adults with obesity, or with overweight and at least one weight-related condition.^[7][8] UnitedHealthcare publishes its own criteria for its plans; see our UnitedHealthcare page.

Other FDA-approved uses. Wegovy is also FDA-approved to reduce the risk of major cardiovascular events in adults with established cardiovascular disease and either obesity or overweight, and Zepbound to treat moderate to severe obstructive sleep apnea in adults with obesity.^[7][8] Some plans review these uses separately from weight loss. Ask your plan whether that applies to you, and ask your prescriber whether either use fits your situation.

Weight Engage. Optum Rx offers employers and health plans a weight management program called Weight Engage, which it describes as combining benefit navigation, behavioral coaching, and access to care, with Calibrate, Omada Health, and Virta Health named as participating companies in an April 30, 2026 Optum article.^[9] Whether you have it depends on your employer or plan. If your benefits materials mention it, ask how it affects your GLP-1 coverage.

What changed in 2026

January 1, 2026. Versions of the Premium Standard Formulary effective on this date list Wegovy, Saxenda, and the Zepbound auto-injector pen with prior authorization and the “++” benefit design note, and list the Zepbound “subcutaneous solution” listing as excluded.^[2]

July 1, 2026. Versions effective on this date list Zepbound KwikPen as excluded, and at least one adds Wegovy HD with prior authorization. Wegovy, Saxenda, and the Zepbound auto-injector pen remain listed with prior authorization.^[3][4]

The formulary itself states that medications may move to a higher tier or be excluded from coverage on January 1 or July 1 of each year.^[2] Employers also revisit their own plan decisions every plan year. A medication covered today can be excluded next year, and the reverse, so a benefit you have now is worth confirming again at open enrollment. For how other pharmacy benefit managers have handled these drugs, see our pages on CVS Caremark and Express Scripts.

Medicare and individual plans

Medicare Part D. Plans with Medicare drug coverage follow federal Part D rules, whichever company manages the pharmacy benefit. The law lets Part D exclude “agents when used for anorexia, weight loss, or weight gain,” so a GLP-1 prescribed for weight loss alone is generally not covered under basic Part D coverage.^[10] Part D plans may cover a GLP-1 for another FDA-approved use, such as type 2 diabetes, and federal rules let plans offering enhanced alternative coverage add supplemental drug benefits.^[11] Separately, CMS is running the Medicare GLP-1 Bridge, a demonstration from July 1, 2026 through December 31, 2027 that gives eligible Part D enrollees access to certain GLP-1 drugs for weight management outside the regular Part D benefit.^[12] Ask your plan, and ask CMS or 1-800-MEDICARE whether the Bridge applies to you. Our pages on Medicare Part D and GLP-1 coverage and the Medicare GLP-1 Bridge cover the details.

Medicaid. If Optum Rx manages a state Medicaid pharmacy benefit, the state sets the coverage rules. Our page on the BALANCE model and state Medicaid explains how state coverage works.

Individual and marketplace plans. Coverage depends on the plan you bought. The plan documents, not the PBM name on the card, decide whether weight loss drugs are included.

How to check your own plan in ten minutes

You do not need to guess, and you do not need to wait for a denial letter. Three routes, fastest first:

Ask your HR benefits team. If you have an employer plan, the single decisive fact is whether your plan includes weight loss medication coverage. HR or your benefits portal can answer that directly.

Call the number on your pharmacy benefit card. Optum Rx’s formulary booklets direct members to the number on their member ID card for the most current list.^[2] Ask three questions. Does my plan include coverage for weight loss medications? If so, which GLP-1 medications are on my formulary for weight management, and at what tier? And which prior authorization criteria apply to my plan?

Check your plan’s drug list. Log in to the Optum Rx app or your plan’s website and search for semaglutide or tirzepatide. Read the indication notes and the tier carefully; a listing under diabetes coverage does not mean weight management is covered.

If the benefit exists on your plan, your next step is the paperwork. Our guide to GLP-1 prior authorization walks through the documentation these requests usually need, including BMI records, weight-related conditions, and lifestyle history.

If your plan says no

Plenty of people with Optum Rx cards land here, through no fault of their own. What you do next depends on why the answer was no.

The denial was about criteria or documentation. This is often fixable. A documented BMI, weight-related conditions noted explicitly in your chart, and recorded lifestyle efforts address the usual criteria. HealthCare.gov says you generally have 180 days from a denial notice to file an internal appeal, and if that appeal is denied, you can in many cases ask for an independent external review.^[13][14] Start with our guide on what to do when insurance denies your GLP-1.

The medication you want is not on your formulary. Ask your plan how to request a formulary exception. The Optum Rx formulary says you, your authorized representative, or your prescriber can ask for a coverage request on an excluded medication by calling customer service.^[2] Your prescriber’s documentation of why the formulary alternative is not appropriate for you is what carries the request. For individual and small-group plans that must cover essential health benefits, federal rules require an exception process, with a decision due within 72 hours on a standard request and within 24 hours when circumstances are urgent.^[15] Employer plans follow different federal claim rules, and your plan documents state the exact limits that apply to you.

Your plan does not include the benefit. An appeal generally cannot override a plan exclusion, because the medication is not a covered benefit on your plan. You can ask HR whether weight loss coverage is under consideration for the next plan year, check whether another plan at open enrollment includes it, and ask your prescriber whether any other covered use applies to you. Beyond that, the options are outside insurance:

• Manufacturer savings and self-pay options. Novo Nordisk and Eli Lilly each publish savings and self-pay terms, and the terms change. Our page on GLP-1 savings programs compares them.
• Cash-pay telehealth programs. Some prescribe brand-name medications and some prescribe compounded medications. Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality, and they are not the same as brand-name products.^[16] Our page on compounded GLP-1 without insurance explains how that route works.

Prices vary by program, medication, and dose. Compare the total cost: medication, dose increases, visits, labs, shipping, membership fees, and cancellation terms. At most telehealth programs, a licensed provider reviews your health history and decides whether a prescription is appropriate. The full insurance coverage overview can help you weigh the options side by side.

Transformation Health does not accept payment from providers. How we make money.

Citations

[1] UnitedHealth Group. “Our Businesses” (Optum Rx listed under Optum). Accessed 2026-10-16. https://www.unitedhealthgroup.com/who-we-are/businesses/optum.html

[2] Optum Rx. “2026 Premium Standard Formulary,” effective January 1, 2026 (plan sponsor booklet hosted on Optum Rx’s content site). Accessed 2026-10-16. https://contenthub-aem.optumrx.com/content/dam/contenthub/rx-assets/en/documents/clients/eaton-corp/2026-Eaton-Premium-Standard-Formulary-Booklet.pdf

[3] Optum Rx. “2026 Premium Standard Formulary,” effective July 1, 2026 (plan sponsor copy). Accessed 2026-10-16. https://www.rit.edu/humanresources/sites/rit.edu.humanresources/files/Benefits/2026%20July%20OptumRx%20Formulary.pdf

[4] Optum Rx. “2026 Premium Standard Formulary,” effective July 1, 2026 (plan sponsor copy). Accessed 2026-10-16. https://6281346.fs1.hubspotusercontent-na1.net/hubfs/6281346/forms-and-brochures/2026/compass-rose-2026_OptumRx_Formulary.pdf

[5] Optum Rx. “2026 Premium Standard Formulary,” effective July 1, 2026 (State of Michigan Civil Service Commission version hosted on Optum Rx’s content site). Accessed 2026-10-16. https://contenthub-aem.optumrx.com/content/dam/contenthub/rx-assets/en/documents/clients/som/2026-State-of-Michigan-Premium-Formulary.pdf

[6] Optum. “Weight Engage: An Innovative Weight Management Solution” (Optum Rx pharmacy benefit management page for employers and plan sponsors). Accessed 2026-10-16. https://business.optum.com/en/pharmacy-benefit-management/affordability/weight-management.html

[7] U.S. Food and Drug Administration. WEGOVY (semaglutide) injection and tablets, prescribing information. Novo Nordisk. Revised 06/2026. Accessed 2026-10-16. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s025lbl.pdf

[8] U.S. Food and Drug Administration. ZEPBOUND (tirzepatide) injection, prescribing information. Eli Lilly and Company. Highlights revised 08/2026. Accessed 2026-10-16. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806Orig1s041correctedlbl.pdf

[9] Optum. “Supporting better health through sustainable weight management” (Optum newsroom), April 30, 2026. Accessed 2026-10-16. https://www.optum.com/en/newsroom/medical-mental-health-care/supporting-better-health-sustainable-weight-management.html

[10] 42 U.S.C. 1395w-102(e)(2)(A) (definition of covered Part D drug; exclusions). Accessed 2026-10-16. https://www.law.cornell.edu/uscode/text/42/1395w-102

[11] 42 CFR 423.104(f)(1) (enhanced alternative coverage; supplemental benefits). Accessed 2026-10-16. https://www.law.cornell.edu/cfr/text/42/423.104

[12] Centers for Medicare and Medicaid Services. “Medicare GLP-1 Bridge.” Accessed 2026-10-16. https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge

[13] HealthCare.gov (Centers for Medicare and Medicaid Services). “Internal appeals.” Accessed 2026-10-16. https://www.healthcare.gov/appeal-insurance-company-decision/internal-appeals/

[14] HealthCare.gov (Centers for Medicare and Medicaid Services). “External review.” Accessed 2026-10-16. https://www.healthcare.gov/appeal-insurance-company-decision/external-review/

[15] 45 CFR 156.122(c) (prescription drug benefits: standard and expedited exception requests). Accessed 2026-10-16. https://www.law.cornell.edu/cfr/text/45/156.122

[16] U.S. Food and Drug Administration. “Compounding and the FDA: Questions and Answers.” Accessed 2026-10-16. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

Important disclosures

Coverage information on this page is current as of 2026-10-16, is general and educational, and changes frequently. It does not represent the terms of your specific plan and is not legal advice. Confirm current benefits, formulary status, and prior authorization requirements directly with your insurance company: call the member services number on your insurance or pharmacy benefit card, or ask your HR benefits team if you have an employer plan.